Catalyzing the critical path initiative: FDA's progress in drug development activities
暂无分享,去创建一个
S. Amur | J. Woodcock | S. Buckman-Garner | A. Parekh | M. Geanacopoulos | C. Clingman | S. Mccune | M. Rocca | S. McCune | R. Oneill | R. Barratt | I. Hills | S. Buckman‐Garner | Shashi Amur